MBN-101

Spectrum of activity:	Gram-positive  &  Gram-negative
Details of activity:	Antibacterial agent against a broad range of gram-positive and gram-negative pathogens
Institute where first reported:	Microbion Corporation
Year first mentioned:	2015
Highest developmental phase:	Phase 2
Development status:	Active

Chemical structure(s):
Canonical SMILES:	C1CS[Bi](S1)SCCS[Bi]2SCCS2
Isomeric SMILES:	C1CS[Bi](S1)SCCS[Bi]2SCCS2
InChI:	InChI=1S/3C2H6S2.2Bi/c3*3-1-2-4;;/h3*3-4H,1-2H2;;/q;;;2*+3/p-6
InChI Key:	GUTNLKRPYCTIHX-UHFFFAOYSA-H
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/10327332

External links:
Guide to Pharmacology:	pravibismane
Main Source:	https://microbioncorp.com/pipeline/
Citation:	https://www.escmid.org/escmid_publications/escmid_elibrary/?q=MBN-101&id=2173&L=0&x=0&y=0&tx_solr%5Bfilter%5D%5B0%5D=main_filter_eccmid%253Atrue